Vident Advisory’s Prothena Corp PRTA Stock Holding History

Vident Advisory’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,639	Closed	-$205K	–	1383
2023 Q4	$205K	Buy	+5,639	New	+$217K	0.01%	1204

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vident Advisory's PRTA Position: Q1 2024 in Review

Vident Advisory sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 5,639 shares — an estimated $205K sold.

Vident Advisory first reported a position in PRTA in Q4 2023 and held it in 1 quarter. The position peaked at $205K in Q4 2023. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

Vident Advisory reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
Vident Advisory sold 5,639 Prothena Corp shares in Q1 2024, an estimated $205K.
Vident Advisory first reported a position in Prothena Corp in Q4 2023 and held it in 1 quarter.
Vident Advisory's Prothena Corp position peaked at $205K in Q4 2023.
169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on Vident Advisory's 13F filing for Q1 2024, filed 14 May 2024.